Engineered Reactive Oxygen Species (ROS)‐Responsive Artificial H + /Cl − Ion Channels for Targeted Cancer Treatment
Angewandte Chemie International Edition · 2025
DOI: 10.1002/anie.202419800 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2025. Verfasst von Chunyan Jia und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Cellular Stress Biology, Fujian Provincial Key Laboratory of Innovative Drug Target Research, MOE Key Laboratory of Spectroch…. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Ion Channels, Antineoplastic Agents. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science, Technology and Innovation Commission of Shenzhen Municipality, Xiamen University.
Abstract (Originalsprache)
Reactive oxygen species (ROS)‐responsive ion channels regulate the ion flow across the membranes in response to alterations in the cellular redox state, playing a crucial role in cellular adaptation to oxidative stress. Despite their significance, replicating ROS‐responsive functionality in artificial ion channels remains elusive. In this study, we introduce a novel class of artificial H + /Cl − ion channels activatable by elevated ROS levels in cancer cells. ROS‐induced decaging of the phenylboronate group triggers the rapid release of the channel‐forming units, leading to self‐assembly of the H‐bonded cascades facilitating the synergistic transport of H + and Cl − ions, with H + /Cl − ion transport selectivity of 7.7. Upon activation, ROS‐C‐Cl exhibits significant apoptotic activity against human breast cancer cells, achieving an IC 50 of 2.8 μM, comparable to that of paclitaxel. Exploiting the intrinsic oxidative microenvironment of cancer cells, along with the enhanced oxidative stress arising from H + /Cl − co‐transport, ROS‐C‐Cl demonstrates exceptional selectivity in targeting cancer cells with a selectivity index of 10.2 over normal breast cells, outperforming that of paclitaxel by 19.4 folds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Cellular Stress Biology, Fujian Provincial Key Laboratory of Innovative Drug Target Research, MOE Key Laboratory of Spectrochemical Analysis and Instrumentation, School of Pharmaceutical Sciences…
- Shenzhen Research Institute of Xiamen University Shenzhen, Guangdong 518057, China.
- School of Biological Sciences, Nanyang Technological University 60 Nanyang Drive, Singapore 637551, Singapore.
ORCID-Profile: Changliang Ren
Förderung
- National Natural Science Foundation of China
- Science, Technology and Innovation Commission of Shenzhen Municipality
- Xiamen University
- Natural Science Foundation of Fujian Province
Zitieren
APA
Jia, C., Luo, D., Zhou, J., Xie, X., Yuen In Lam, H., Li, P., Mu, Y., Zeng, Z., & Ren, C. (2025). Engineered Reactive Oxygen Species (ROS)‐Responsive Artificial H + /Cl − Ion Channels for Targeted Cancer Treatment. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202419800
Vancouver
Jia C, Luo D, Zhou J, Xie X, Yuen In Lam H, Li P, et al. Engineered Reactive Oxygen Species (ROS)‐Responsive Artificial H + /Cl − Ion Channels for Targeted Cancer Treatment. Angewandte Chemie International Edition. 2025. doi:10.1002/anie.202419800
BibTeX
@article{Jia2025,
author = {Jia, Chunyan and Luo, Daoxin and Zhou, Jin and Xie, Xiaopan and Yuen In Lam, Hilbert and Li, Pengzhe and Mu, Yuguang and Zeng, Zhiping and Ren, Changliang},
title = {Engineered Reactive Oxygen Species (ROS)‐Responsive Artificial H + /Cl − Ion Channels for Targeted Cancer Treatment},
journal = {Angewandte Chemie International Edition},
year = {2025},
doi = {10.1002/anie.202419800}
}
EUVIMED